A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Post-operative Peripheral Neuropathic Pain
Interventions
DRUG

Qutenza

capsaicin patch

Trial Locations (29)

256 01

Site CZ42019 Hospital, Benešov

266 01

Site CZ42026 Hospital, Beroun

616 00

Site CZ42008 Onco Clinic, Brno

626 00

Site CZ42001 Sv. Anna Hospital, Brno

370 03

Site CZ42007 Private Practice, České Budějovice

580 02

Site CZ42015 Hospital, Havlíčkův Brod

268 01

Site CZ42029 Hospital, Hořovice

500 02

Site CZ42009 University Hospital, Hradec Králové

586 02

Site CZ42004 Hospital, Jihlava

360 02

Site CZ42022 Hospital, Karlovy Vary

339 00

Site CZ42017 Hospital, Klatovy

794 01

Site CZ42025 Private Practice, Krnov

460 01

Site CZ42016 Hospital, Liberec

293 01

Site CZ42023 Hospital, Mladá Boleslav

549 01

Site CZ42020 Hospital, New Town

770 00

Site CZ42010 University Hospital, Olomouc

746 00

Site CZ42012 Hospital, Opava

701 00

Site CZ42002 University Hospital, Ostrava

320 00

Site CZ42006 University Hospital, Pilsen

141 00

Site CZ42013 Hospital, Prague

141 01

Site CZ42018 Rheumatological Institute, Prague

152 00

Site CZ42005 University Hospital, Prague

161 00

Site CZ42021 Military Hospital, Prague

513 01

Site CZ42027 Hospital, Semily

356 00

Site CZ42011 Hospital, Sokolov

415 00

Site CZ42024 Hospital, Teplice

686 02

Site CZ42028 Hospital, Uherské Hradiště

566 01

Site CZ42014 Private Practice, Vysoké Mýto

760 01

Site CZ42003 Bata Hospital, Zlín

All Listed Sponsors
lead

Astellas Pharma s.r.o.

INDUSTRY

NCT02171182 - A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter